Clinical Trial Update: Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy(LSG) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the effect of gabapentin on kidney function in obese patients undergoing laparoscopic sleeve gastrectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Obesity

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Tanta University | Conditions: Acute Kidney Injury, Obesity (BMI > 35) | Phase 4 | Status: COMPLETED